A Retreat In Medical Devices
Executive Summary
Just a couple of years ago, combining medical device and pharmaceutical businesses made sense. Managed care would reign in the profitability of drug businesses, bringing it more in line with medical devices, and a bundled offering would appeal to bigger customers. But managed care's bark has been worse than its bite. With drug profits on the rise, pharmaceutical companies are bailing out of the medical device business in record numbers.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.